Zhejiang Supor Pharmaceuticals now is belonging to SyncoZymes Group, which is specialized among enzymes, intermediates, APIs and FDF. enjoying the advantages from group company`s biocatalytic technology development and chemical-enzymatic synthesis process development, Supor Pharma could deliver to our clients with APIs with cost competitiveness, quality management and sustainability ensurance by leading synthetic biology technology and green manufacturing.
more >
Year of Establishment:
2002
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
100-500
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO)
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: